Cytokinetics CYTK Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on trailing twelve months.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's operating margin?
- Cytokinetics (CYTK) reported operating margin of -605.1% in Q1 2026.
- How has Cytokinetics's operating margin changed year-over-year?
- Cytokinetics's operating margin increased by 79.4% year-over-year, from -2,943.3% to -605.1%.
- What is the long-term trend for Cytokinetics's operating margin?
- Over 5 years (2020 to 2025), Cytokinetics's operating margin has grown at a 32.8% compound annual growth rate (CAGR), from -168.3% to -695.4%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.